Walder Wyss advised Gilde Healthcare Partners, Polaris Partners, Invus Capital and BioMedInvest as investors on the financing. Vischer advised Noema Pharma. Noema Pharma, a Swiss clinical-stage…
Walder Wyss advised Gilde Healthcare Partners, Polaris Partners, Invus Capital and BioMedInvest as investors on the financing. Vischer advised Noema Pharma. Noema Pharma, a Swiss clinical-stage…
You must be a Standard 1 Year member to access this content.
…
You must be a Standard 1 Year member to access this content.